Letter: immunogenicity is not the root cause for loss of response to anti-TNF agents in patients with IBD in TDM era. Alsoud D, Verstockt B, Vermeire S. Aliment Pharmacol Ther 2022;55:885-886.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alsoud D, Verstockt B, Vermeire S. Letter: immunogenicity is not the root cause for loss of response to anti-TNF agents in patients with IBD in TDM era. Aliment Pharmacol Ther 2022;55:885-886.
PMID: 35315101